Fanconi anemia (FA) is a rare inherited disorder in which the body cannot properly repair a specific kind of DNA damage. Its three defining features are progressive bone marrow failure, physical differences present from birth (such as thumb or forearm abnormalities and short stature), and a much higher lifetime risk of cancer. Diagnosis rests on a chromosome breakage test confirmed by genetic testing, and the only treatment that can restore normal blood production is a stem cell transplant, backed by lifelong cancer surveillance.
Below I walk through the symptoms families usually notice first, how the diagnosis is made, and how treatment and follow-up are organized.
What Causes Fanconi Anemia?
FA is caused by a harmful change (variant) in one of more than 20 genes that work together in the FA pathway. This pathway repairs DNA interstrand crosslinks, a type of damage that glues the two strands of DNA together so the cell cannot copy them. The genes most often involved are FANCA, FANCC, and FANCG.
Most forms are inherited in an autosomal recessive pattern: a child must inherit one faulty copy from each parent. When both parents are carriers, each pregnancy has a 1 in 4 chance of FA. One form, caused by the FANCB gene, is X-linked and affects mainly boys.
Blood-forming stem cells divide constantly, so they are especially vulnerable to unrepaired DNA damage. Over time they die off or acquire further genetic errors, which explains both the bone marrow failure and the cancer risk.
Fanconi Anemia Symptoms
Symptoms vary widely, even between siblings with the same gene change. Some children are diagnosed at birth because of visible differences; others look entirely typical and are only diagnosed when their blood counts fall, or even in adulthood after an unusual cancer.
Physical Signs Present From Birth
A majority of people with FA have at least one physical finding, although around a quarter to a third have none. Common ones include:
- Thumb and forearm anomalies: absent, small, or extra thumbs, or a missing or underdeveloped radius bone.
- Short stature and low birth weight.
- Skin pigment changes: café-au-lait spots and areas of lighter or darker skin.
- Small head (microcephaly) and small eyes.
- Kidney and urinary tract differences, such as a single or horseshoe kidney.
- Heart defects, hearing loss, and genital or fertility problems in some patients.
Blood-Related Symptoms
Marrow failure usually appears during childhood, often before the age of 10. It develops gradually as pancytopenia, a fall in all three blood cell lines. Low platelets and enlarged red cells (a raised MCV) are often the earliest clues on a blood count.
| Cell line affected | Lab finding | Symptoms |
|---|---|---|
| Red blood cells | Anemia, often with a high MCV | Tiredness, pale skin, breathlessness |
| Platelets | Thrombocytopenia | Easy bruising, nosebleeds, pinpoint rash (petechiae) |
| White blood cells | Neutropenia | Frequent or severe infections, mouth ulcers |
Cancer Risk
People with FA have a much higher risk of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), especially in childhood and young adulthood. Later in life the main concern becomes squamous cell carcinoma of the head and neck, esophagus, and anogenital region, which tends to appear decades earlier than in the general population.
How Fanconi Anemia Is Diagnosed
FA should be considered in any child or young adult with unexplained marrow failure, typical birth anomalies, early-onset MDS or AML, or a squamous cell cancer at an unusually young age. It is one of the key hematological conditions to rule out before labeling a young patient’s marrow failure as acquired aplastic anemia.
- Chromosome breakage test: the screening test of choice. Blood cells are exposed to DNA-crosslinking chemicals, diepoxybutane (DEB) or mitomycin C (MMC). FA cells show far more chromosome breaks and abnormal shapes than normal cells.
- Genetic testing: a gene panel or sequencing identifies the exact variants, which confirms the diagnosis and allows testing of siblings and family planning.
- Complete blood count and bone marrow examination: these gauge the degree of marrow failure and look for early signs of MDS or leukemia.
- Baseline organ assessment: kidney ultrasound, hearing test, hormone and growth assessment, and eye and heart checks as needed.
Occasionally the breakage test is falsely reassuring because some blood cells have spontaneously corrected their own gene defect, a phenomenon called somatic mosaicism. In that case, testing skin cells (fibroblasts) can settle the question.
Treatment Options
Treatment is planned by a multidisciplinary team, ideally at a center with experience in FA. The choice depends on how low the blood counts are, whether MDS or leukemia has developed, and whether a suitable donor is available.
Hematopoietic Stem Cell Transplant
Hematopoietic stem cell transplantation (HSCT) is the only treatment that cures the marrow failure. Because FA cells cannot repair DNA damage well, patients are highly sensitive to chemotherapy and radiation. Transplant centers therefore use reduced-intensity, usually fludarabine-based, conditioning regimens designed for FA. A matched sibling donor who does not have FA is preferred when available.
A transplant replaces the blood-forming system only. It does not fix the gene defect in the rest of the body, so the risk of solid tumors remains, and some transplant factors such as chronic graft-versus-host disease can increase it.
Supportive and Medical Therapy
- Androgens such as oxymetholone or danazol can raise blood counts in many patients for a time, though they are not curative and need monitoring of liver function.
- Transfusions of red cells or platelets when counts fall too low, used sparingly before transplant.
- Growth factors and prompt antibiotic treatment for infections.
Gene Therapy
Gene therapy, which inserts a working copy of the faulty gene into the patient’s own stem cells, is being studied, particularly for FANCA. It remains investigational and is offered only within clinical trials.
Lifelong Monitoring and Cancer Prevention
Because cancer risk persists for life, regular surveillance matters as much as treating the blood counts. A typical plan includes:
- Blood counts every few months and periodic bone marrow examinations before transplant.
- Head and neck examinations by an experienced specialist, usually every 6 to 12 months from adolescence.
- Gynecologic screening for women and HPV vaccination for all patients.
- Avoiding tobacco and alcohol, and keeping X-rays and CT scans to what is truly necessary.
- Endocrine follow-up for growth, thyroid function, diabetes, and bone health.
When to See a Doctor
Ask for an evaluation if a child has an absent or unusual thumb, a missing forearm bone, café-au-lait spots with short stature, or a blood count showing unexplained low platelets or anemia with large red cells. Adults with known FA should seek prompt care for a mouth sore that does not heal within two weeks, a lump in the neck, persistent hoarseness, trouble swallowing, fever, or unusual bleeding.
Frequently Asked Questions
Is Fanconi anemia the same as aplastic anemia?
No. FA is an inherited cause of marrow failure, while aplastic anemia is usually acquired and immune-mediated. The distinction matters because FA patients need adjusted transplant regimens and lifelong cancer screening.
Can adults be diagnosed with Fanconi anemia?
Yes. Some people have mild or no physical signs and normal counts for years. They may be diagnosed in adulthood after developing MDS, AML, or an early squamous cell cancer, or after severe reactions to chemotherapy.
Does a stem cell transplant cure Fanconi anemia?
It cures the bone marrow failure and removes the leukemia risk tied to the old marrow. It does not correct the gene defect in other tissues, so screening for head, neck, and anogenital cancers must continue.
Should siblings be tested?
Yes. Brothers and sisters should have breakage or genetic testing, both to identify those who are affected and to confirm that any sibling being considered as a stem cell donor does not have FA.
Key Takeaways
- FA is an inherited DNA repair disorder causing marrow failure, birth anomalies, and a high cancer risk.
- The chromosome breakage test and genetic testing confirm the diagnosis.
- Stem cell transplant with FA-specific conditioning is the only cure for the marrow failure.
- Lifelong cancer surveillance is essential, even after a successful transplant.
